110541 ⎘
ssDNA viruses; Details; Parvoviridae; Dependovirus, e.g. adenoassociated viruses Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
NEDDYLATION-ACTIVATING ENZYME INHIBITORS AS VIRAL SENSITIZERS AND USES THEREOF
#2IMMUNE TOLERANCE INDUCTION TO VIRAL CAPSIDS
#3METHODS OF MAKING AND USING UNIVERSAL CENTRALIZED INFLUENZA VACCINE GENES
#4NOVEL METHODS OF USING ADENO-ASSOCIATED VIRUS 11 (AAV11)
#5BOCAPARVOVIRUS SMALL NONCODING RNA AND USES THEREOF
#6DEVELOPMENT OF A HIGHLY EFFICIENT SECOND GENERATION FENTANYL-CONJUGATE VACCINE TO TREAT FENTANYL ADDICTION
#7REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE
#8LYOPHILIZED NON-VIRAL DNA VECTOR COMPOSITIONS AND USES THEREOF
#9RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS WITH CD14 PROMOTER AND USE THEREOF
#10Phagemid Vector
#11SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERS
#12Prostate neoantigens and their uses
#13VACCINE AND METHOD FOR TREATING CANCER
#14COMPOSITIONS AND METHODS FOR THE TREATMENT OF TAUOPATHY
#15AAV CAPSID CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#16RAAV WITH CHEMICALLY MODIFIED CAPSID
#17small noncoding RNA and uses thereof
#18Recombinant adeno-associated virus vectors with CD14 promoter and use thereof
#19MODIFIED ADENO-ASSOCIATED VIRAL VECTORS FOR USE IN GENETIC ENGINEERING
#20Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells
#21Methods of making and using universal centralized influenza vaccine genes
#22SARS-COV-2 antigen polypeptide, recombinant adeno-associated virus expressing the polypeptide, and vaccine containing the virus
#23rAAV with chemically modified capsid
#24RAAV with chemically modified capsid
#25COMPOSITIONS AND METHODS FOR MULTIPLEXED TUMOR VACCINATION WITH ENDOGENOUS GENE ACTIVATION
#26Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells
#27Adenovirus polynucleotides and polypeptides
#28Methods of transfection for large cargo using poly(beta-amino esters)
#29RAAV with chemically modified capsid
#30Bocaparvovirus small noncoding RNA and uses thereof
#31Phagemid vector
#32Adenovirus polynucleotides and polypeptides
#33Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
#34Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
#35Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus (derzsy's disease)
#36Adeno-associated virus with site-directed mutagenesis and site-directed modification and preparation method and application thereof
#37Attenuated parvovirus vaccine for Muscovy duck parvovirus and goose parvovirus (Derzsys disease)
#38EXPRESSION OF VIRUS ENTRY INHIBITORS AND RECOMBINANT AAV THEREFOR
#39EXPRESSION OF VIRUS ENTRY INHIBITORS AND RECOMBINANT AAV THEREFOR
#40Expression of virus entry inhibitors and recombinant AAV therefor
#41Expression of virus entry inhibitors and recombinant AAV thereof
#42Methods for administering recombinant adeno-associated virus virons to humans previously exposed to adeno-associated virus